Log in to save to my catalogue

Atomoxetine in clinical practice

Atomoxetine in clinical practice

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1014100606

Atomoxetine in clinical practice

About this item

Full title

Atomoxetine in clinical practice

Publisher

London: Future Medicine Ltd

Journal title

Future neurology, 2006-05, Vol.1 (3), p.249-258

Language

English

Formats

Publication information

Publisher

London: Future Medicine Ltd

More information

Scope and Contents

Contents

The authors provide clinical suggestions for optimizing the use of atomoxetine in practice. Atomoxetine is a highly specific norepinephrine inhibitor that was developed for the treatment of attention-deficit/hyperactivity disorder (ADHD) in all age groups. In clinical trials, it has a slightly lower effect size (0.2) than stimulants, but these stud...

Alternative Titles

Full title

Atomoxetine in clinical practice

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1014100606

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1014100606

Other Identifiers

ISSN

1479-6708

E-ISSN

1748-6971

DOI

10.2217/14796708.1.3.249

How to access this item